These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33716100)

  • 1. Expandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly-soluble drugs.
    Blaesi AH; Saka N
    Int J Pharm; 2022 Mar; 615():120396. PubMed ID: 33716100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expandable fibrous dosage forms for prolonged drug delivery.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():110144. PubMed ID: 33545806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of excipient molecular weight in drug release by fibrous dosage forms with close packing and high drug loading.
    Blaesi AH; Saka N
    Int J Pharm; 2021 Sep; 606():120009. PubMed ID: 33246051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 2. 3D-micro-patterned dosage forms.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():110211. PubMed ID: 34579874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical strength and gastric residence time of expandable fibrous dosage forms.
    Blaesi AH; Kümmerlen D; Richter H; Saka N
    Int J Pharm; 2022 Feb; 613():120792. PubMed ID: 34363914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 1. Single fibers.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():109918. PubMed ID: 32228997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release.
    Blaesi AH; Saka N
    Int J Pharm; 2024 Jun; ():124360. PubMed ID: 38909925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
    Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
    J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():715-727. PubMed ID: 28866221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.
    Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J
    J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels.
    Cheng Y; Qin H; Acevedo NC; Jiang X; Shi X
    Int J Pharm; 2020 Dec; 591():119983. PubMed ID: 33065220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrous dosage forms by wet 3D-micro-patterning: Process design, manufacture, and drug release rate.
    Blaesi AH; Saka N
    Eur J Pharm Biopharm; 2018 Sep; 130():345-358. PubMed ID: 29932976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot-scale binder jet 3D printing of sustained release solid dosage forms.
    Tan M; Dharani D; Dong X; Maiorana C; Chaudhuri B; Nagapudi K; Chang SY; Ma AWK
    Int J Pharm; 2023 Jan; 631():122540. PubMed ID: 36566828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications.
    Aita IE; Breitkreutz J; Quodbach J
    Eur J Pharm Sci; 2020 Apr; 146():105266. PubMed ID: 32060006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-micro-patterned fibrous dosage forms for immediate drug release.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():218-229. PubMed ID: 29519432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.